ReviewBiomedicines2025

Pentraxin-3 as a Biomarker in Diabetes Mellitus: Insights into Inflammation, Vascular Complications, and Modulation by Antidiabetic Medications.

Roxana-Cristina Dobriceanu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.